Subjects who had active papilledema due to intracranial hypertension or optic disc edema due to new onset (within 21 days of vision loss) optic neuritis or NAION were prospectively included in this study. At baseline presentation, all eyes enrolled with NAION and optic neuritis showed optic disc swelling by clinical ophthalmoscopy. Inclusion criteria required that the average RNFL thickness by OCT in the affected eye(s) be greater than the 95th percentile of controls. Patients enrolled with papilledema had symptoms of intracranial hypertension, bilateral papilledema, and no optic atrophy seen with ophthalmoscopy. Each patient with papilledema had also undergone a brain magnetic resonance imaging (MRI) study with gadolinium and had lumbar puncture confirmation of raised intracranial pressure. Each patient with optic neuritis had undergone MRI with gadolinium of the brain and orbits. This research was conducted with New York Eye and Ear Infirmary Institutional Review Board approval. All subjects were treated in accordance with the Declaration of Helsinki.
Each subject had complete clinical evaluation and threshold perimetry performed with the Humphrey Field Analyzer (Zeiss-Meditec, Inc., Dublin, CA) SITA 24-2 standard perimeter strategy using size III stimulus (expressed as mean deviation, in decibels). The peripapillary RNFL evaluation was performed with SLP in undilated eyes and with OCT, following pupil dilation. For SLP (GDx with enhanced corneal compensation research software, Zeiss-Meditec, Inc.), an elliptical annulus was adjusted to permit measurement of the same peripapillary RNFL region between examinations and eyes. The SLP retardation values were determined within the annulus, which was resampled into 64 circumferential sectors of derived RNFL thickness. The OCT (Stratus version 3; time domain OCT 4 Software, fast RNFL protocol, Zeiss-Meditec, Inc.), was used to obtain a set of three 3.4-mm diameter retinal scans, averaged together to provide the RNFL thickness at 256 points along the circumference of the circular peripapillary scan in each eye. For the HD-OCT (high definition, Cirrus spectral HD-OCT, Zeiss-Meditec, Inc.), a 6 × 6-mm optic disc volume scan was obtained, capturing a cube of data consisting of 200 A-scans from 200 linear B-scans (40,000 points). The time domain OCT was used early in the studies and spectral HD-OCT was used for later cases (a comparison of both methods typically showed that HD-OCT RNFL measures were reduced by 8–12 μm). Both OCT methods provided values for the average RNFL thickness and for the 12 clock-hour sectors around the peripapillary circumference. At least two scans were performed for each method on each eye, and only images centered on the optic disc with signal strength scores of six or greater were analyzed. The same OCT method was used for individuals who had images obtained at one month follow-up.
The RNFL thickness derived from SLP retardance and from OCT was analyzed and the average sampled for the entire peripapillary circumference for OCT and for SLP. Measurements were calculated for 4 quadrants (temporal, superior, nasal, and inferior) by averaging the values for equally distributed 12 clock-hour sectors for OCT (3 sectors per quadrant) and 64 circumferential measurements for SLP (16 measurements per quadrant). For SLP, the fifth and 95th percentiles of RNFL thickness (retardance) in normal controls were determined (provided by Zeiss-Meditec, Inc.;
Table 1) for 32- and 65-year-olds (matched for age of papilledema/optic neuritis patients and NAION patients, respectively) to compare to our data. For OCT, the fifth and 95th percentiles of RNFL thickness in normal controls were determined (
Table 1) (OCT 4 provided by University of Iowa, with mean age 53 years; and HD-OCT provided by Zeiss-Meditec, Inc., for 32- and 65-year-olds). For our study eyes, RNFL was judged abnormally thick by OCT for measurements greater than the 95th percentile of controls (applied separately to time domain OCT and HD-OCT data). Abnormal retardance by SLP or RNFL by OCT was determined for the entire circumference or for quadrant measurements if values were greater than the 95th percentile (swelling) or less than the fifth percentile (atrophy) of controls for normal 32-year-olds, for papilledema and optic neuritis, and for 65-year-olds for NAION eyes (
Table 1). The values of SLP and OCT were compared across all affected eyes at presentation and, when applicable, at one month. A two-tailed Student's t-test and paired t-test were used and
P values reported.